HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Etsuko Okada Selected Research

Adalimumab (Humira)

1/2022Possible beneficial impact of surgical deroofing procedure to cover the disadvantage of adalimumab treatment for hidradenitis suppurativa.
2/2017Lichenoid drug eruption caused by adalimumab: a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Etsuko Okada Research Topics

Disease

7Neoplasms (Cancer)
06/2021 - 07/2006
7Drug Eruptions (Drug Eruption)
01/2021 - 02/2017
5Melanoma (Melanoma, Malignant)
02/2022 - 12/2018
2Fibrosis (Cirrhosis)
09/2014 - 04/2011
2Nephrogenic Fibrosing Dermopathy
09/2014 - 04/2011
2Liver Diseases (Liver Disease)
01/2012 - 03/2008
1Colitis
02/2022
1Diarrhea
02/2022
1Hidradenitis Suppurativa
01/2022
1Lymphatic Metastasis
06/2021
1Extramammary Paget Disease (Paget Disease, Extramammary)
06/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021
1Bullous Pemphigoid (Pemphigoid)
07/2020
1Experimental Melanoma
01/2020
1Exfoliative Dermatitis (Erythroderma)
08/2018
1Cheilitis
02/2018
1Inflammation (Inflammations)
01/2018
1Mycosis Fungoides
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018
1Atrioventricular Block
06/2017
1Hypopituitarism (Sheehan's Syndrome)
06/2017
1Hypothyroidism
06/2017
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2015
1Anetoderma
04/2015
1Dermatofibrosarcoma
08/2012
1Kounis Syndrome
01/2012
1Pulmonary Hypertension
01/2012
1digital ulcers
01/2012
1Systemic Scleroderma (Systemic Sclerosis)
01/2012
1Gangrene
01/2012
1Relative Energy Deficiency in Sport
04/2011
1Mixed Connective Tissue Disease (MCTD)
03/2008
1Ulcer
08/2007
1Eccrine Porocarcinoma
08/2007
1Lymphadenopathy
07/2006

Drug/Important Bio-Agent (IBA)

3NivolumabIBA
02/2022 - 06/2017
3secukinumabIBA
08/2018 - 02/2017
2Immune Checkpoint InhibitorsIBA
02/2022 - 01/2020
2Adalimumab (Humira)FDA Link
01/2022 - 02/2017
2Cell Adhesion Molecule-1IBA
05/2021 - 01/2018
2AntigensIBA
02/2021 - 01/2020
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2Bosentan (Tracleer)FDA Link
01/2012 - 03/2008
1Infliximab (Remicade)FDA Link
02/2022
1Prednisolone (Predate)FDA LinkGeneric
02/2022
1IpilimumabIBA
02/2022
1MethylprednisoloneFDA LinkGeneric
02/2022
1vedolizumabIBA
02/2022
1dermcidinIBA
06/2021
1Biomarkers (Surrogate Marker)IBA
06/2021
1Antimicrobial PeptidesIBA
06/2021
1Cell Adhesion MoleculesIBA
05/2021
1Immunoglobulins (Immunoglobulin)IBA
05/2021
1EpitopesIBA
02/2021
1CytokinesIBA
02/2021
1telaprevirIBA
01/2021
1Small Interfering RNA (siRNA)IBA
11/2020
1KalininIBA
07/2020
1AutoantibodiesIBA
07/2020
1OX40 LigandIBA
01/2020
1OvalbuminIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Androgen Receptors (Androgen Receptor)IBA
05/2018
1enzalutamideIBA
05/2018
1Pharmaceutical PreparationsIBA
05/2018
1Imiquimod (Aldara)FDA LinkGeneric
01/2018
1Interleukin-23 (Interleukin 23)IBA
01/2018
1garenoxacinIBA
11/2017
1Mesylates (Mesylate)IBA
11/2017
1Memantine (Namenda)FDA Link
07/2017
1PiperacillinFDA LinkGeneric
02/2017
1TazobactamFDA LinkGeneric
02/2017
1S100 Proteins (S 100 Protein)IBA
12/2015
1Fibronectins (Fibronectin)IBA
12/2015
1Proteins (Proteins, Gene)FDA Link
12/2015
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
12/2015
1Factor XIIIaIBA
12/2015
1NestinIBA
12/2015
1Matrix Metalloproteinases (MMPs)IBA
04/2015
1Endothelin-1 (Endothelin 1)IBA
09/2014
1Endothelin Receptors (Endothelin Receptor)IBA
09/2014
1Becaplermin (PDGF-BB)FDA Link
08/2012
1CollagenIBA
08/2012
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2012
1GadoliniumIBA
04/2011
1Contrast MediaIBA
04/2011
1CalciumIBA
04/2011
1Cyclin D1IBA
07/2006

Therapy/Procedure

3Therapeutics
02/2022 - 01/2020
2Injections
02/2021 - 02/2018
2Immunotherapy
02/2021 - 01/2020
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2021
1Aftercare (After-Treatment)
02/2021
1Radiotherapy
08/2007
1Myocutaneous Flap
08/2007
1Debridement
08/2007
1Combination Drug Therapy (Combination Chemotherapy)
07/2006